Ocuphire Pharma
summary of prior clinical trials extensively studied in clinical trials across phase and phase by and | Ocuphire Pharma
Company
Deck Type
Deck date
October 2022
Slide
37 of 53
Related slides by other companies
Arbutus Biopharma
Investor Presentation
March 2023
phase a clinical trial weeks a | Arbutus Biopharma
Aeglea BioTherapeutics
Investor Presentation
March 2023
phase clinical trial to generate proof of concept and path to pivotal trial | Aeglea BioTherapeutics
Oculis
Investor Presentation
April 2024
positive phase stage results risking stage trial next step complete stage of phase program to support filing of for treatment lis | Oculis
Arbutus Biopharma
Investor Presentation
November 2023
phase a clinical trial a placebo weeks will be presented at | Arbutus Biopharma
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights